Testing embolization for chronic migraines
Part of Brain & nervous system clinical trials.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with chronic migraine (headaches on 15+ days per month for at least 3 months).
- Your migraines have not responded well to several preventive treatments (refractory).
- You first started having migraines before age 50.
- You do not have other headache disorders (except medication-overuse headache).
- You do not regularly use opioids, cannabis, or medical marijuana.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
This trial tests a treatment that places small coils in an artery behind the ear to reduce migraine days. It might be an option if you have tried at least two preventive medications without success.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This study looks for new biological markers in people whose migraines don't respond to standard treatments. It aims to better understand why some migraines are hard to treat and may help guide future therapies.
This trial tests a minimally invasive procedure that blocks a blood vessel in the brain to reduce migraine attacks. It may help people who have frequent migraines and haven't found relief with standard migraine medications.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.